Features of cytokine profile in patients with sarcoidosis

par N. M. Lazareva, O. P. Baranova, I. V. Kudryavtsev, N. A. Arsentieva, N. E. Liubimova, T. P. Ses’, M. M. Ilkovich, Areg A. Totolian
Publié 2020

CXCR3 chemokine receptor ligands in sarcoidosis

par N. M. Lazareva, O. P. Baranova, I. V. Kudryavtsev, N. A. Arsentieva, N. E. Liubimova, T. P. Ses’, M. M. Ilkovich, Areg A. Totolian
Publié 2021

Peripheral blood B cell subsets from patients with various activity of chronic sarcoidosis

par N. M. Lazareva, I. V. Kudryavtsev, O. P. Baranova, M. K. Serebriakova, A. A. Bazhanov, T. P. Ses’, M. M. Ilkovich, A. A. Totolian
Publié 2020

CD39⁺ EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME

par I. V. Kudryavtsev, N. M. Lazareva, O. P. Baranova, A. S. Golovkin, D. V. Isakov, M. K. Serebriakova, T. P. Ses’, M. M. Ilkovich, Areg A. Totolian
Publié 2019

CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS

par N. M. Lazareva, O. P. Baranova, I. V. Kudryavtsev, D. V. Isakov, N. A. Arsentieva, N. E. Liubimova, T. P. Ses’, M. M. Ilkovich, A. A. Totolian
Publié 2021